title: Response to taxanes in triple negative breast cancer.
authors.forename: Nilufer
authors.initials: N
authors.lastname: Bulut
authors.forename: Sadettin
authors.initials: S
authors.lastname: Kilickap
authors.forename: Ebru
authors.initials: E
authors.lastname: Sari
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D019398:Genes, BRCA1; D018734:Genes, erbB-2; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D011960:Receptors, Estrogen / Q000032:analysis
chemical_list: D011960:Receptors, Estrogen; D004317:Doxorubicin; D003520:Cyclophosphamide; D017239:Paclitaxel; D002945:Cisplatin